In renal collecting ducts, a vasopressin-induced cAMP increase results in the phosphorylation of Aquaporin-2 (AQP2) water channels at S256 and its redistribution from intracellular vesicles to the apical membrane. Hormones that activate protein kinase C (PKC) proteins counteract this process. To determine the role of the putative kinase sites in the trafficking and hormonal regulation of human AQP2, three putative casein kinase II (S148, S229, T244), one PKC (S231) and one protein kinase A (S256) site were altered to mimic a constitutively non-phosphorylated/phosphorylated state and expressed in MDCK cells. Except for S256 mutants, seven correctly-folded AQP2 kinase mutants trafficked as wild-type AQP2 to the apical membrane via forskolin-sensitive intracellular vesicles. With or without forskolin, AQP2-S256A was localized in intracellular vesicles, while AQP2-S256D was localized in the apical membrane. PMA-induced PKC activation following forskolin treatment resulted in vesicular distribution of all AQP2 kinase mutants, whereas all were still phosphorylated at S256. Our data indicate that in collecting duct cells, AQP2 trafficking to vasopressin-sensitive vesicles is phosphorylation independent, that phosphorylation of S256 is necessary and sufficient for expression of AQP2 in the apical membrane, and that PMA-induced PKC-mediated endocytosis of AQP2 is independent of the AQP2 phosphorylation state.
Summary
In renal collecting ducts, a vasopressin-induced cAMP increase results in the phosphorylation of Aquaporin-2 (AQP2) water channels at S256 and its redistribution from intracellular vesicles to the apical membrane. Hormones that activate protein kinase C (PKC) proteins counteract this process. To determine the role of the putative kinase sites in the trafficking and hormonal regulation of human AQP2, three putative casein kinase II (S148, S229, T244), one PKC (S231) and one protein kinase A (S256) site were altered to mimic a constitutively non-phosphorylated/phosphorylated state and expressed in MDCK cells. Except for S256 mutants, seven correctly-folded AQP2 kinase mutants trafficked as wild-type AQP2 to the apical membrane via forskolin-sensitive intracellular vesicles. With or without forskolin, AQP2-S256A was localized in intracellular vesicles, while AQP2-S256D was localized in the apical membrane. PMA-induced PKC activation following forskolin treatment resulted in vesicular distribution of all AQP2 kinase mutants, whereas all were still phosphorylated at S256. Our data indicate that in collecting duct cells, AQP2 trafficking to vasopressin-sensitive vesicles is phosphorylation independent, that phosphorylation of S256 is necessary and sufficient for expression of AQP2 in the apical membrane, and that PMA-induced PKC-mediated endocytosis of AQP2 is independent of the AQP2 phosphorylation state.
Introduction
In humans, the kidney is the prime organ for regulation of body fluid osmolarity, which is maintained within strict boundaries. To fine-tune this balance, principal cells of the renal collecting duct reabsorb water from pro-urine, which is under control of the anti-diuretic hormone arginine vasopressin (AVP). Upon hypovolemia or hypernatremia, pituitaryderived AVP binds its V2-receptor in the basolateral membrane of these cells and initiates an intracellular cAMP signaling cascade that causes a transient increase in cytosolic calcium (1) and the activation of protein kinase A (PKA), which in turn phosphorylates homotetrameric Aquaporin-2 (AQP2) water channels and possibly other proteins. Consequently, AQP2-containing vesicles fuse with the apical membrane, rendering the principal cells water permeable (2;3). Driven by an osmotic gradient, water will then enter these cells via AQP2 and will exit the cells via AQP3 and AQP4, located in the basolateral membrane, a process in which urine is concentrated.
Using antibodies that recognize S256-phosphorylated AQP2 (p-AQP2), Nishimoto et al. were able to show that in vivo, AVP-induced redistribution of AQP2 from vesicles to Phosphorylation of AQP2 (CKII) proteins (15;16) . At present, however, it is unknown whether the AVPcounteracting PKCs mediate the re-distribution of AQP2 to intracellular vesicles via direct or indirect (e.g. through CKII) (de-)phosphorylation of AQP2 or whether it occurs independent of the AQP2 phosphorylation state.
Besides modulating the steady state localization of a protein in response to hormonal stimulation, the transit of proteins from the endoplasmic reticulum (ER) to their final subcellular location can also be a phosphorylation dependent process. For example, phosphorylation of the N-methyl-D-aspartate (NMDA) receptor NR1 and caveolin-1 enables these proteins to exit the ER (17;18), whereas translocation of numerous proteins from the trans Golgi network (TGN) to intracellular compartments or the plasma membrane and vice versa is also regulated by phosphorylation events (19) (20) . Since such phosphorylation events can be transient, lasting only minutes (21;22) , the importance of a phosphorylation event can be easily missed, which will not occur when such a site is constitutively phosphorylated or non-phosphorylated. Several studies have shown that the negative charge introduced by phosphorylation can often be mimicked by changing a phosphorylation site Ser/Thr residue for a Glu or Asp (23;24) , while phosphorylation of such a site can be prevented by changing it to an Ala residue (25;26) .
Experimental procedures

Expression constructs.
For expression of AQP2-S256A and AQP2-S256D in MDCK cells, the encoding cDNA fragments were cut from pT7Ts-AQP2-S256A and pT7Ts-AQP2-S256D constructs (6;28) with BglII and SpeI and cloned into the BglII and XbaI sites of the mammalian expression vector pCB6 (29) .
To generate pCB6 constructs for expression of the other kinase site mutants, three point PCR reactions were performed. For this, sense primers for AQP2-S148A (5'-
AAGAGCCTGGCGGAGCGCCT-3'), S231D (5'-CAAGAGCCTGGATGAGCGCCT GG-3'), T244A (5'-GAGCCGGACGCCGATTGGGA-3') and T244E (5'-GGAGCCGGACGAGGATTG GGAGG-3') or their corresponding antisense primers were used in combination with a pT7Ts reverse primer (5'GCTTAGAGACTCCATTCGGG3') or T7 primer, respectively, in a standard PCR reaction with pT7Ts-AQP2 (28) as a template. The resulting fragments were isolated, and a second PCR reaction, using both fragments as template, combined with the pT7Ts reverse and T7 primer was performed to generate the full-length mutated AQP2 Side specific biotinylation.
MDCK cells were seeded at 1.5 x 10 5 cells/cm 2 on 9.6-cm 2 polycarbonate filters (Corning Costar Europe, Badhoevedorp, The Netherlands), grown and treated as described above.
Next, the cells were washed twice with ice-cold PBS-CM and incubated twice for 20 min at 4°C with 500 µl of 1.5 mg/ml Sulfo-NHS-SS-Biotin (Pierce, Rockford, IL) in biotinylation buffer (10 mM triethanolamine, 2 mM CaCl 2 , and 125 mM NaCl, pH 8.9) applied to the apical surface of the cells. Subsequently, the filters were incubated for 5 min with quenching solution (50mM NH 4 Cl in PBS-CM) at 4°C and rinsed twice with cold PBS-CM. After the filters were cut from their plastic support, 1 ml of lysisbuffer (150mM NaCl, 20mM Tris-HCl pH 8.0, 5 mM EDTA, 1% Triton X-100, 0.2% BSA, 1mM phenylmethylsulfonyl fluoride (PMSF), 5 µg/ml leupeptin and 5 µg/ml pepstatin) was added and incubated for 30 min at 37°C. Subsequently, the cells were scraped, and transferred to Eppendorf tubes. After centrifugation for 5 min, the supernatant was added to streptavidin beads (30 µl/sample), which had been pre-washed twice with high salt buffer (500 mM NaCl, 5 mM EDTA, 50 mM Tris-HCl (pH 7.5), 0.1% triton X-100) and twice with lysisbuffer. After incubation for 16 hours at 4°C, the beads were centrifuged for 5 min and washed twice with high salt buffer, twice with lysisbuffer and once with 10 mM Tris-HCl (pH 7.5). Finally, the beads were sucked dry with a 30-g needle, resuspended in 30 µl of 1x Laemlli buffer and denatured for 30 min at 37°C.
Orthophosphate labeling.
Transfected MDCK cells were seeded as described for side-specific biotinylation. Two inhibit dephosphorylation. Subsequently cells were scraped and homogenized in 750 µl ice cold lysis buffer (100 mM Tris-HCl, 150 mM NaCl, 2 mM EDTA, 0.5% Nadesoxycholate, 0.1% SDS, 0.5% Nonidet P40) containing 10 mM NaF and 0.5 mM Na 3 VO 4 . The lysates were transferred to eppendorf tubes and centrifuged for 10 min at 4°C. The cleared lysate was subjected to immunoprecipitation.
Immunoprecipitation.
Results
Trafficking of AQP2 to intracellular vesicles is phosphorylation independent.
To determine the role of phosphorylation of S148, S229, S231, T244 and S256 in the targeting and regulation of shuttling of AQP2, all these sites were independently mutated into alanines to mimic a non-phosphorylated state, or into glutamic (T244) or aspartic acids (others) to mimic a phosphorylated state (Fig. 1) . Eucaryotic expression constructs coding for these proteins were stably transfected into MDCK cells. Immunoblot analysis of the selected clones revealed that, except for AQP2-S148D, all AQP2 mutants were mainly expressed as unglycosylated 29 kDa proteins, which is also the most prominent band for wt-AQP2 in MDCK cells (Fig. 4) . AQP2-S148D, however, was mainly expressed as 29 and 32 kDa AQP2 proteins (Fig. 2) , which has been shown to be indicative for AQP2 proteins retained in the ER (34) . Therefore, this mutant was left out of further analyses.
To determine the effects of the introduced mutations on the targeting of AQP2 from the organelle of synthesis (ER) to intracellular vesicles, the cell lines were treated with indomethacin to lower endogenous cAMP levels and subjected to immunocytochemistry.
With the exception of AQP2-S148D and AQP2-S256D, CLSM analysis revealed a vesicular localization for all AQP2 mutants that was similar to that of wt-AQP2 (Fig. 3, left column). AQP2-S148D revealed a dispersed intracellular staining, which did not change with forskolin or forskolin/PMA treatments and is typical for ER-retained proteins. Strikingly, AQP2-S256D was, in contrast to wt-AQP2 and all other AQP2 mutants, expressed in the apical membrane.
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Phosphorylation of S256 is necessary for expression of AQP2 in the apical membrane.
To determine whether the introduced kinase site mutations affected the cAMP-induced re-distribution of AQP2 from intracellular vesicles to the apical membrane, all cell lines were treated with forskolin and subjected to immunocytochemistry. CLSM analysis revealed that all AQP2 mutants were mainly expressed in the apical plasma membrane as has been previously found for wt-AQP2, except for AQP2-S256A (Fig. 3 , middle column). Of this latter mutant, the vesicular localization did not change upon forskolin treatment, which indicated that phosphorylation of S256 is essential for re-distribution of AQP2 from vesicles to the apical membrane.
PMA-induced endocytosis of AQP2 from the apical plasma membrane is independent of the phosphorylation state of AQP2.
In several in vivo studies, it has been shown that hormones and PMA that activate the PKC pathway, counteract the AVP-induced re-distribution of AQP2 from vesicles to the apical membrane in collecting duct cells and, therefore, the concentration of urine (13;35) . To test whether this process could be simulated in MDCK cells and whether the kinase site mutants act differently upon activation of the PKC pathway, all cell lines were pre-treated with forskolin and subsequently treated with forskolin and PMA followed by immunocytochemistry. CLSM analysis revealed that wt-AQP2 as well as all kinase site mutants were re-distributed from the apical membrane to intracellular vesicles (Fig. 3. right column). The vesicular localization of AQP2-S256A was not changed by the combined forskolin-PMA treatment. These results indicated that neither phosphorylation of the PKC consensus site nor modification of any other putative kinase site was needed for PMA-induced translocation of AQP2 from the apical membrane to intracellular vesicles. Since AQP2-S256D is also internalized with PMA, these data also suggested that the PKC-induced redistribution of AQP2 to intracellular vesicles is an event that is independent of de-phosphorylation of the PKA phosphorylation site.
To biochemically establish expression of the AQP2 proteins in the apical membrane, all cell lines were treated as above and subjected to an apical cell surface biotinylation assay.
Immunoblotting revealed that forskolin treatment strongly increased the apical membrane expression of all AQP2 proteins (only shown for wt-AQP2, AQP2-S229A/D and AQP2-S231A/D), except for AQP2-S256A and AQP2-S256D (Fig. 4) . AQP2-S256A was not detected in the apical membrane, whereas the apical membrane expression of AQP2-S256D in unstimulated cells was not further increased with forskolin. Incubation with forskolin-PMA following forskolin treatment again decreased the apical membrane expression of all kinase site mutants to undetectable levels. Immunoblotting of equivalents of the biotinylated and lysed cells revealed that all cell lines expressed well detectable levels of wt-AQP2 or of the AQP2 mutants (Fig. 4, total) .
Forskolin specifically enhances phosphorylation of S256.
To determine whether the forskolin and forskolin-PMA induced redistribution of AQP2
co-incided with a changed phosphorylation of the AQP2 protein, wt10 cells and AQP2-S256A expressing cells were not stimulated or treated with forskolin or forskolin-PMA in the presence of radio-active orthophosphate. After this treatment, AQP2 proteins were immunoprecipitated from lysed cells, split into two equal portions and immunoblotted for AQP2 or loaded on a gel and exposed to film. Immunoblotting revealed that per cell line equal amounts of AQP2 were loaded for each condition tested (Fig. 5, lower panel) .
Determination of the level of phosphorylation of wt-AQP2 in wt10 cells revealed that wt-AQP2 was already phoshorylated without stimulation, which was, following normalization for the amounts of AQP2 loaded, increased two-fold upon stimulation with forskolin.
In contrast to wt-AQP2, AQP2-S256A was not labelled in unstimulated, forskolinstimulated or forskolin-PMA treated cells, whereas the AQP2-S256A expression was higher than of wt-AQP2 (Fig. 5) . These results showed that under steady state conditions only S256 in AQP2 is detected as being phosphorylated and that its level of phosphorylation is increased with forskolin.
PMA-induced endocytosis of AQP2 is independent of S256 de-phosphorylation.
Data obtained for AQP2-S256A and AQP2-S256D described above demonstrated the importance of phosphorylation of S256 to re-distribute AQP2 from intracellular vesicles to the apical membrane. We also wanted to determine whether forskolin-induced translocation to the plasma membrane and subsequent re-location to intracellular vesicles with forskolin-PMA treatment co-incides with an increased, respectively decreased, phosphorylation of AQP2 at S256. Therefore, the different cell lines were treated as described above and lysed. Immunoblotting of the obtained samples, using antibodies specifically recognizing S256-phosphorylated AQP2 (4), revealed that forskolin strongly increased the level of S256 phosphorylation of all AQP2 kinase site mutants that were redistributed from vesicles to the apical membrane ( Fig. 6 ; shown for wt-AQP2, AQP2-S229A/D and AQP2-S231A/D), with the exception of AQP2-S256A/D. Neither AQP2-S256A, nor AQP2-S256D could be detected with these antibodies, presumably because these mutations disrupt the epitope recognized by the antibody (not shown).
Surprisingly, treatment with forskolin-PMA following forskolin treatment did not appear to reduce the level of phosphorylation of S256 (Fig. 6) . These results demonstrated that the PMA induced re-distribution of AQP2 from the apical membrane to intracellular vesicles occurred independent of de-phosphorylation of S256.
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Discussion
AQP2 routing to cAMP-sensitive storage vesicles is a phosphorylation independent process.
In this study, putative kinase sites were changed into Ala or Glu/Asp residues to investigate the involvement of putative phosphorylation sites in AQP2 routing and regulation of its shuttling in MDCK cells.
Immunocytochemical analysis revealed that, except for AQP2-S148D, all AQP2 kinase site mutants were routed to intracellular vesicles, as shown by the observed spot-like structures. The dispersed staining of AQP2-S148D (Fig. 3) is typical for an ER-retained protein. This was confirmed by the appearance of a 32 kDa band on immunoblot (Fig. 2) , which has been shown to represent a high mannose glycosylated form of AQP2 (32) . One could argue that the ER retention of AQP2-S148D indicates that AQP2 is phosphorylated at S148 while residing in the ER and needs to be de-phosphorylated to continue its route to storage vesicles. Inconsistent with this, however, is that AQP2-S148A, which can not be phosphorylated at S148, is not impaired in its routing to intracellular vesicles (Fig. 3) .
Also, S148 is located close to or is part of transmembrane domain four ( Fig. 1 ) and transmembrane domains are considered to be highly sensitive to amino acid changes, resulting in improperly folded proteins. Indeed, many of the misfolded AQP2 proteins, encoded in patients suffering from Nephrogenic Diabetes Insipidus, are caused by mutations in transmembrane domains (36) . Most likely, therefore, AQP2-S148D is a Phosphorylation of S256 is necessary and sufficient for localization of AQP2 in the apical plasma membrane.
Using LLC-PK 1 cells expressing AQP2-S256A, it has been shown that phosphorylation of S256 is needed for AQP2 translocation from vesicles to the basolateral membrane (7;8) . The vesicular localization of AQP2-S256A in oocytes indicated that also in these cells, phosphorylation of S256 was essential for plasma membrane expression (6) . In contrast, the exclusive plasma membrane expression of AQP2-S256D in oocytes indicated that this protein mimics constitutively-phosphorylated AQP2, since this localization is identical to that of wt-AQP2, which is in these cells under basal conditions phosphorylated at S256 to a high level (6) . Because the level of S256 phosphorylation could not be modulated in oocytes, its role in the regulation of AQP2 shuttling could not be studied further in these cells.
In MDCK cells, however, induction of the cAMP pathway by AVP, cAMP or forskolin is needed to induce the re-distribution of wt-AQP2 from storage vesicles to the apical membrane (37), which co-incides with an increased level of S256 phosphorylation (Figs 5, 6) . In these cells, forskolin treatment did not change the vesicular localization of AQP2-S256A (Fig. 3) , which was underscored by the lack of detection of AQP-S256A in the apical membrane with the biotinylation assay (Fig. 4) . This clearly showed that phosphorylation of S256 in wt-AQP2 is also needed for AQP2 translocation to the apical plasma membrane. Recently, it was speculated that S256 needs to be phosphorylated by by guest on November 6, 2017
http://www.jbc.org/ Downloaded from the Golgi CKII and subsequently de-phosphorylated before its itinerary to storage vesicles could be continued (38) . Co-localization studies using antibodies that recognize the Golgi marker proteins 58k and giantin, however, did not reveal any co-localization with AQP2-S256A nor AQP2-S256D (not shown), which showed that in MDCK cells (de-)phosphorylation of S256 is not needed to exit the Golgi complex.
In contrast to AQP2-S256A, AQP2-S256D was already expressed in the apical plasma membrane without stimulation of the cAMP cascade with forskolin ( Figs 3,4) . This The following model might explain these seemingly contradictions: AQP2 is thought to reside in two vesicle pools: a recycling pool, which continuously shuttles AQP2 to and from the apical membrane, but rapidly changes the balance of AQP2 expression to the apical membrane upon hormonal stimulation, and a storage pool, which is transported along microtubules to the apical pole and delivers its cargo to the recycling pool upon stimulation (42) (43) (44) (45) . This hypothesis is consistent with the biphasic increase in vasopressin-induced AQP2-mediated water permeability in collecting ducts (46) and MDCK cells (PMT Deen, unpublished data), because the latter process is much slower than the former. The study presented here is consistent with this hypothesis of two vesicle pools: the storage vesicles are detected as clear intracellular spots, as observed for AQP2-S256A, and wt-AQP2 and other AQP2 kinase mutants in unstimulated cells, whereas AQP2 in the recycling pool is detected as being localized in the apical membrane, as found for AQP2-S256D with or without stimulation or for wt-AQP2 in stimulated cells.
The assumption that the latter protein cycle to and from the apical membrane is corroborated by the data that treatment of stimulated wt-AQP2 or AQP2-S256D cells with cytochalasin D, which affects the actin cytoskeleton, resulted in numerous vesicles distributed throughout the cytoplasm (not shown). The constitutively phosphorylated state of S256, mimicked in AQP2-S256D, thus conveys the protein a strong tendency to localize in recycling vesicles instead of storage vesicles.
Of further interest is that apical cell surface biotinylation experiments revealed that, although AQP1 and AQP2-N220, which is an AQP1 protein in which the C-tail is exchanged for that of AQP2, are already expressed in the apical membrane of MDCK cells without stimulation, forskolin still caused a nearly two-fold increase in their apical membrane expression (47) . In contrast, the reporter protein TMR-Plap (47) and AQP2-S256D (Fig. 4) did not show any increase in apical expression with forskolin. These data suggest that, within the continuous shuttling process between recycling vesicles and the plasma membrane, AQP2-S256D (and TMR-Plap) in unstimulated cells is preferentially localized in the apical membrane, in contrast to AQP1 and AQP2-N220. Since the tendency of AQP2-S256D to localize in the apical membrane is continuously present, a slow uni-directional transport of AQP2-S256D from storage vesicles to the apical membrane and/or a strongly reduced endocytosis of AQP2-S256D from the plasma membrane following the three days of culturing, provides an explanation for the apical expression of AQP2-S256D in unstimulated cells, for which PKA tethering and by guest on November 6, 2017
http://www.jbc.org/ Downloaded from cytoskeletal rearrangements might not be needed. Therefore, we believe that the apical membrane localization of AQP2-S256D is not dependent on the translocation machinery needed to shuttle wt-AQP2 from storage vesicles to the apical membrane, but does reveal that, on a long term, phosphorylation of AQP2 is sufficient for apical membrane localization.
PMA-induced endocytosis of AQP2 occurs independently of the phosphorylation state of AQP2
In shown by the lack of phosphate labeling of AQP2-S256A (Fig. 5) . Thirdly, PMAforskolin treatment following forskolin stimulation re-distributed all kinase site mutants from the apical membrane to vesicles throughout the cell, which indicated the PMAinduced endocytosis overruled the apical membrane targeting triggered by S256
phosphorylation. This was underscored by the finding that all kinase site mutants were still phosphorylated at S256 to a high extent although they were located in vesicles (Fig.   6 ).
Our data, therefore, strongly suggest that a PKC-induced retrieval of AQP2 from the apical membrane of collecting duct cells is a process that occurs independently of the phosphorylation state of AQP2. For S256 in AQP2, this hypothesis is in line with data from Zelenina et al., who showed that in isolated rat inner medulla prostaglandin E 2 induces internalization of AQP2 without decreasing the amount of PKA-phosphorylated AQP2 (35) . In collecting ducts, vasopressin is known to induce a de-and repolymerization of the actin cytoskeleton (48) , and cytochalasins, which disrupt actin filaments, markedly inhibit the vasopressin response in target epithelia (49) . In addition, it has been shown that Rho, which belongs to a family of proteins involved in the regulation of F-actin polymerisation, inhibits the translocation of AQP2 to the plasma membrane in cultured cells (40;41) . Since PKC activation has been shown to disintegrate the actin cytoskeleton in confluent MDCK monlayers (14;50) , it is therefore most likely that the inhibitory effect of PMA-activated PKC pathways on vasopressin-induced AQP2 translocation to the apical membrane is conveyed through cytoskeletal rearrangements. 
